Terumo’s Azur HydroPack Peripheral Coil System Launched in United States

December 11, 2023—Terumo Medical Corporation announced the United States launch of the Azur HydroPack peripheral coil system. Terumo received FDA clearance for the Azur HydroPack coil system earlier this year. It is now commercially available in the United States.

According to the company, the Azur HydroPack is a soft, universal-shaped platinum and hydrogel coil designed to find and fill empty space within the vessel. Terumo’s hydrogel technology creates a gel core for mechanical occlusion.

Terumo stated that the Azur HydroPack peripheral coil system has a true 0.018-inch primary wind and is available in long lengths ranging from 5 to 60 cm. It allows for flexible sizing and can be deployed through 2.4- or 2.8-F microcatheters in a single-coil platform. The soft coil design paired with an enhanced pusher allows for ease of delivery, optimized trackability, and microcatheter stability.

Additionally, the device has no requirements for vessel-diameter sizing other than placement of an anchor coil, which may reduce the amount of inventory required to support a wide variety of peripheral embolization procedures, noted the company.

“Our unique hydrogel technology is a key differentiator as it creates a gel core and promotes new tissue growth versus the basic thrombogenic response of a traditional platinum coil,” commented Terumo’s Chief Medical Officer Michael J. Martinelli, MD, in the company’s press release. “It also will allow physicians to fill open vessel space confidently and efficiently while minimizing reperfusion. Additionally, the tight packing and durable occlusion associated with hydrogel technology put the Azur HydroPack coil system in a category of its own in the peripheral coil market.”